StocksMedium•29 September 2026•
1 min read
Judge Denies Pfizer and Moderna Bid to Dismiss Bayer Vaccine Patent Lawsuit
Key Facts
1A federal judge in Delaware denied attempts by Moderna and Pfizer to dismiss lawsuits filed by Bayer alleging patent infringement.
2Bayer accuses the vaccine makers of infringing on a crop-based genetic-engineering patent with their Covid-19 vaccines.
A federal judge in Delaware denied attempts by Moderna and Pfizer to dismiss lawsuits filed by Bayer alleging patent infringement. Reuters reported that Bayer accuses the vaccine makers of infringing on a crop-based genetic-engineering patent with their Covid-19 vaccines, as the court found sufficient grounds for the case to move forward.
BAYRY closed at $14.46 on September 28, 2026, while MRNA closed at $197.28 and PFE closed at $28.72 on the same date. Bayer claims the mRNA vaccines utilize its proprietary technology, potentially advancing multi-billion dollar royalty claims as the litigation proceeds to the discovery phase.